Irbesartan prevents myocardial remodeling in experimental thyrotoxic cardiomyopathy.
Kim BH, Cho KI, Kim SM, Kim JY, Choi BG, Kang JH, Jeon YK, Kim SS, Kim SJ, Kim YK, Kim IJ.
Kim BH, et al. Among authors: kim jy, kim ss, kim ij, kim yk, kim sj, kim sm.
Endocr J. 2012;59(10):919-29. doi: 10.1507/endocrj.ej12-0111. Epub 2012 Jun 27.
Endocr J. 2012.
PMID: 22785259
Free article.